+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction



The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction



Journal of Thrombosis and Thrombolysis 11(2): 171-174




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 047727317

Download citation: RISBibTeXText

PMID: 11406733

DOI: 10.1023/a:1011284902244


Related references

The role of low-molecular-weight heparins in the management of unstable angina and non-ST elevation myocardial infarction. Acta Medica Indonesiana 40(4): 228-232, 2008

Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non-Q-wave acute myocardial infarction. American Journal of Cardiology 85(8A): 2C-9C, 2000

Heparins for unstable angina and non-ST segment elevation myocardial infarction. American Family Physician 79(7): 560-562, 2009

Low molecular weight heparins in the management of unstable angina/non-Q-wave myocardial infarction. Seminars in Thrombosis and Hemostasis 25(Suppl. 3): 113-121, 1999

Low molecular weight heparins (enoxaparin) in the management of unstable angina: the TIMI studies. Thrombolysis in Myocardial Infarction. Heart 82(Suppl. 1): I15-I17, 1999

Low molecular weight heparin in the treatment of acute coronary syndromes without ST-segment elevation: unstable angina and non-Q-wave myocardial infarction. Medicina Clinica 115(15): 583-586, 2000

Low-molecular-weight heparins in unstable angina and non-Q-wave myocardial infarction. Medicina Clinica 116(16): 638-639, 2001

Recent update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: role of antiplatelet therapy. Clinical Cardiology 27(3): 119-120, 2004

Antithrombotic therapy in unstable angina/non-ST elevation myocardial infarction: the evolving role of low-molecular-weight heparin. Journal of Invasive Cardiology 12 Suppl E: E1, 2000

Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction). American Journal of Cardiology 108(10): 1395-1400, 2011

Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction. Critical Pathways in Cardiology 9(2): 55-81, 2010

Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?. American Journal of Cardiology 104(5 Suppl): 4c-8c, 2009

Management of unstable angina and non-ST-segment elevation myocardial infarction. Journal of the Louisiana State Medical Society 153(6): 306-311, 2001

Acute management of unstable angina and non-ST segment elevation myocardial infarction. Einstein 13(3): 454-461, 2016

New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarction. Archives of Internal Medicine 161(5): 674-682, 2001